Holen Sie sich die Stockscreener-App
1.73
4.95%
-0.09
Vorhandelsmarkt:
1.70
-0.03
-1.73%
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
Is NRx Pharmaceuticals Inc. stock a buy before product launchesWeekly Loss Report & Technical Confirmation Alerts - mfd.ru
Market Recap: Can NRx Pharmaceuticals Inc Equity Warrant weather a recessionRisk Management & Verified Entry Point Detection - baoquankhu1.vn
Inflation Data: Is NRx Pharmaceuticals Inc. Equity Warrant likely to announce a buybackMarket Growth Summary & Weekly Momentum Picks - baoquankhu1.vn
Aug Gainers: Will NRx Pharmaceuticals Inc stock hit new highs in YEARJuly 2025 Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer By Investing.com - Investing.com Australia
NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer - Investing.com
FDA fast track puts ketamine-based therapy in spotlight for suicide care - MSN
Market Review: Can NRx Pharmaceuticals Inc Equity Warrant maintain its current growth rateEarnings Overview Report & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Published on: 2026-01-31 19:02:41 - baoquankhu1.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Significant Increase in Short Interest - MarketBeat
NRx Pharmaceuticals completes debt repayment, ends 2025 debt-free - MSN
NRx Pharmaceuticals (NASDAQ:NRXP) Stock Rating Lowered by Zacks Research - MarketBeat
Movement Recap: How does NRx Pharmaceuticals Inc perform in inflationary periodsSwing Trade & Real-Time Stock Entry Alerts - baoquankhu1.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Volatility Watch: How volatile is NRx Pharmaceuticals Inc Equity Warrant stockPortfolio Return Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Breakout Zone: Should value investors consider Sprouts Farmers Market IncInsider Buying & Real-Time Stock Entry Alerts - baoquankhu1.vn
What is the dividend yield of NRx Pharmaceuticals Inc. Equity Warrant2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
NRx Pharmaceuticals (NASDAQ: NRXP) sets virtual annual meeting for March - MSN
Aug Catalysts: Is NRx Pharmaceuticals Inc Equity Warrants growth already priced inQuarterly Trade Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
NRx Pharmaceuticals (NASDAQ: NRXP) Sets Virtual Annual Meeting for March - mychesco.com
FDA Fast Track Puts Ketamine-Based Therapy in Spotlight for Suicide Care - mychesco.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP) and Qiagen (QGEN) - The Globe and Mail
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 By Investing.com - Investing.com India
Short Squeeze: What is the dividend yield of NRx Pharmaceuticals IncPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Pullback Watch: Can GRDN withstand a market correctionTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus
NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements - The Globe and Mail
Milestone Patient Data Eclipsing 70,000 on Real World Use - openPR.com
NRx Pharmaceuticals Received Notice of Noncompliance - TradingView
NRx Pharmaceuticals Announces 2025 Annual Meeting Date and Record Date - citybiz
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - The Manila Times
Sentiment Review: What are NRx Pharmaceuticals Incs recent SEC filings showingPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be submitted to the FDA in Support of NRX-100 Approval - marketscreener.com
Biotech NRx Pharma outlines its business at H.C. Wainwright investor event - Stock Titan
NRx Pharmaceuticals (NASDAQ:NRXP) Given "Buy" Rating at BTIG Research - MarketBeat
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Sahm
Milestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
FinancialContentMilestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 - Digital Journal
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression - citybiz
NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset - TechStock²
About Us - FinancialContent
NRx Pharma Strengthens NRX-100 Approval Case With 70,000-Patient Real-World Ketamine Data - Nasdaq
Why Did NRXP Stock Surge 21% Pre-Market Today? - Stocktwits
NRx Pharmaceuticals' NRX-100 Receives FDA Fast Track Designation for Treatment of Suicidal Ideation in Depression and Bipolar Depression - Quiver Quantitative
Is NRx Pharmaceuticals Inc backed by strong institutional buying2025 Sector Review & Verified Stock Trade Ideas - baoquankhu1.vn
Earnings Report: Should I hold or sell NRx Pharmaceuticals Inc Equity Warrant stock in 2025Quarterly Trade Review & Daily Oversold Bounce Ideas - Bộ Nội Vụ
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):